BD Pharmingen- FITC Rat anti-Mouse CD34_BD Pharmingen
参考图片
Identification of CD34+ and CD34- subpopulations of hematopoietic progenitors. BALB/c bone marrow cells were treated with Mouse BD Fc Block™ purified anti-CD16/CD32 mAb 2.4G2 (Cat. No. 553141/553142) and stained with either FITC-conjugated anti-mouse CD34 (Clone RAM34, right panel) or a FITC-conjugated rat IgG2a, κ isotype control (clone R35-95, Cat. No. 553929, left panel), followed by staining with an APC Lineage Cocktail (Cat. No. 558074) to identify major lineage committed cells. The contour plots were derived from the gated events based on light scattering characteristics of leukocytes and fluorescence characteristics of the CD34 and Lineage markers . Flow cytometry was performed on a BD FACSCanto™ System.
Identification of CD34+ and CD34- subpopulations of hematopoietic progenitors. BALB/c bone marrow cells were treated with Mouse BD Fc Block™ Purified anti-CD16/CD32 (Cat. No. 553141/553142) and stained with either FITC Rat Anti-Mouse CD34 (Cat. No. 560238/553733, right panel) or a FITC Rat IgG2a, κ isotype control (Cat. No. 553929, left panel), followed by APC Lineage Cocktail (Cat. No. 558074) to identify major lineage committed cells. The contour plots were derived from the gated events based on light scattering characteristics of leukocytes and fluorescence characteristics of the CD34 and Lineage markers . Flow cytometry was performed on a BD FACSCanto™ System.
本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/kangti/9398.html